Episode Summary
Discover how exercise may do far more than improve fitness in cancer care: it is linked to lower mortality, better treatment completion, stronger immune responses, and even cancer-suppressive effects. Learn why muscle strength, cardiorespiratory fitness, and regular training could play a powerful role during and after treatment.
Exercise and cancer outcomes are explained through both epidemiological evidence and proposed biological mechanisms. The lecture distinguishes physical activity, exercise, and physical fitness, then shows that higher physical activity before and after diagnosis, as well as greater muscle strength and cardiorespiratory fitness, are consistently associated with about a 30–44% lower risk of all-cause and cancer-specific mortality, including in advanced cancer.
It also examines how exercise may support treatment. Key effects include improved chemotherapy completion rates, better drug delivery through increased tumor blood flow and vascularization, reduced hypoxia, and possible reductions in tumor growth and aggressiveness. Learners are also introduced to practical measures such as handgrip strength, walking tests, cardiopulmonary exercise testing, and questionnaires used to assess prognosis.
A major focus is the biology behind these effects: exercise can reduce chronic inflammation, improve immune and metabolic function, alter body composition, and influence hormones, cytokines, adipokines, and myokines. Myokines released during muscle contraction may directly suppress cancer cell growth and enhance anti-tumor immunity. Overall, the lecture presents exercise as a meaningful supportive strategy across the cancer continuum, while noting that optimal exercise prescriptions and long-term mechanisms still require further research.
